-
Measuring the Elephant in the Room: Quantifying Legal Barriers to AI Processing of Full?Text in Systematic Reviews
Sep 9, 2025, 16:22 PM -
The Association Between COVID-19 Vaccination and the Healthcare Resource Use Related to COVID-19 in Typical Rural Residents in Japan
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Evaluation of RSVpreF Vaccine for Preventing RSV Among Older Adults With High Risk Under Taiwan National Vaccination Program
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Using Structured Expert Elicitation to Estimate Long-Term Organ Damage Risk in an Ultrarare Condition: A STEER Case Study
Sep 9, 2025, 16:22 PM -
Unintended Consequences of MFN Pricing: Global Access Risks and Revenue Impact
Sep 9, 2025, 16:22 PM -
Cost of First-Line Treatment of Hepatocellular Carcinoma With the Immune Checkpoint Inhibitor-Based Regimens STRIDE and Atezolizumab Plus Bevacizumab in Brazil
Sep 9, 2025, 16:22 PM -
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Assessment of Oncology Analog HTA Outcomes and Evidence Needs in France and Germany
Sep 9, 2025, 16:22 PM -
Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)
Sep 9, 2025, 16:22 PM -
An Exploration of Implementing Herd Immunity Into Static Models for Economic Evaluation of Vaccines
Sep 9, 2025, 16:22 PM -
Weighting the OrPhar-SEFH MCDA Framework for Its Use in Ultrarare Kidney Diseases
Sep 9, 2025, 16:22 PM -
Heatstroke Is Associated With an Increased Risk of Chronic Headache: A Retrospective Cohort Study in Germany
Sep 9, 2025, 16:22 PM -
Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study
Sep 9, 2025, 16:22 PM -
Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study
Sep 9, 2025, 16:22 PM -
Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidences in the Core Obesity and Diabetes Model
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Regulatory Divergence in Expedited Oncology Approvals: Evidence, Pathways, and Timelines Across FDA, EMA, TGA, and PMDA
Sep 9, 2025, 16:22 PM -
Air Pollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern?
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM
